I’m having similar issues with 4DX, who has a doctor as a CEO and they also seem to over hype things and fail to deliver despite having a revolutionary product at cheaper prices. Sounds familiar?
Xperience is fresh to market but won’t be surprised a year on minimal sales traction has been gained. Then like 4DX you start to question the product as I am now on NXS pre existing suite which hasn’t delivered.
Ann: Update on expected revenue for H1, page-46
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.010(4.00%) |
Mkt cap ! $72.92M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 26.0¢ | 25.0¢ | $16.48K | 63.53K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 150 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 70882 | 2 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
26.0¢ |
Change
0.010 ( 2.00 %) |
||||
| Open | High | Low | Volume | ||
| 25.0¢ | 26.0¢ | 25.0¢ | 14413 | ||
| Last updated 15.58pm 31/05/2024 ? | |||||
| NXS (ASX) Chart |